An investigation of MCPH1/BRIT1 in cervical cancer demonstrated decreased expression of MCPH1/BRIT1 in 61.3% (19/31) of cases at the mRNA level and 69.8% (44/63) at the protein level in cervical tumour tissues compared to non-tumour tissues. Here, MCPH1 is linked to uterine cervix neoplasm.